Companies Using Nicotine Drug Testing to Decide on Candidates

Many health and life insurance companies are using nicotine/cotinine drug testing to evaluate prospective clients for tobacco use. Using tobacco products can tremendously change the health of users. Long-term use of tobacco products can increase the risk of many life threatening diseases including lung cancer, heart disease, stroke and respiratory infections.

The nicotine drug testing will be able to determine an active tobacco user, a user who recently quit or a non-tobacco users. The nicotine test can also detect the amount of chemicals in a non-tobacco user who have been exposed to to 2nd hand smoke.

If a person is using nicotine replacement products in place of  tobacco the health and insurance companies may measure the amount of anabasine in your body. Anabasine is a chemical found in tobacco, but is not in any commercial nicotine replacement products.  Therefore, if a test is positive for anabasine, then you know that person is still using tobacco products.

High levels of nicotine or cotinine signify an active tobacco user. A balanced level of cotinine means this person has quit tobacco use for two or three weeks. If small amounts are found, this indicates a non-tobacco user who has been exposed to second hand smoke, or a person who has quit tobacco use for several weeks.

There are many other uses for nicotine drug tests. Sometimes an employer will require the test, if they prohibit smoking. Smoking can raise the risk of medical complications, so before some surgical procedures or drug therapies, a nicotine test can be used.

The drug test is also used for medical purposes when a nicotine overdose may be present. Some symptoms of a mild overdose include, dizziness, nausea, uncontrollable drooling, and weakness. For a more serious overdose, a person could experience, seizures, coma’s, difficulty breathing, and a drop in heart rate and blood pressure.


Comments are closed.